RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: myocardial infarction
Accession: DOID:5844
browse the term
Definition: A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia. (DO)
Synonyms: exact_synonym: Cardiovascular Stroke; Heart Attacks; Myocardial Infarct; Myocardial Infarctions; cardiovascular strokes; heart attack; myocardial infarcts
narrow_synonym: MCI1; MCI2; post-operative myocardial infarction
broad_synonym: F7-RELATED CONDITION
related_synonym: MYOCARDIAL INFARCTION, DECREASED SUSCEPTIBILITY TO; MYOCARDIAL INFARCTION, PROTECTION AGAINST; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2
primary_id: MESH:D009203
alt_id: MIM:608446 ; MIM:608557
xref: EFO:0000612 ; EFO:0009953 ; NCI:C27996
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCC9
ATP binding cassette subfamily C member 9
IAGP
ClinVar Annotator: match by term: Myocardial infarction
ClinVar
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
G
ACE
angiotensin I converting enzyme
treatment susceptibility
IEA IAGP EXP ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Type 1;DNA:deletion:intron:IVS16+1464-1751del (human) associated with Myocardial Reperfusion Injury
ClinVar CTD RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:25741868 PMID:28492532 PMID:15118671 PMID:23959549 PMID:15671045 PMID:7555560 PMID:21975128 More...
RGD:1331525 , RGD:9685449 , RGD:1558664 , RGD:7829785 , RGD:6893480
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
treatment
ISO
RGD
PMID:15671045 PMID:23959549
RGD:1558664 , RGD:9685449
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACTA2
actin alpha 2, smooth muscle
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
G
ACVR2A
activin A receptor type 2A
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:147,844,517...147,930,822
Ensembl chr 2:147,844,517...147,930,826
G
ACVR2B
activin A receptor type 2B
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:15625312
RGD:9681751
NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
G
ADD1
adducin 1
no_association
IAGP
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:17082469 PMID:16420563
RGD:5147995 , RGD:5148001
NCBI chr 4:2,843,844...2,930,062
Ensembl chr 4:2,843,844...2,930,076
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
RGD
PMID:21326342
RGD:5686351
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADIPOR1
adiponectin receptor 1
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr 1:202,940,825...202,958,572
Ensembl chr 1:202,940,826...202,958,572
G
ADIPOR2
adiponectin receptor 2
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
G
ADORA1
adenosine A1 receptor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12160945
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
G
ADORA3
adenosine A3 receptor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12160945 PMID:20132822
NCBI chr 1:111,499,429...111,503,633
Ensembl chr 1:111,499,429...111,503,633
G
ADRA2B
adrenoceptor alpha 2B
IAGP
RGD
PMID:12535806
RGD:1559314
NCBI chr 2:96,112,876...96,116,571
Ensembl chr 2:96,112,876...96,116,571
G
ADRB1
adrenoceptor beta 1
IEA ISO
GAD RGD
PMID:15118671 PMID:17143192
RGD:1331525 , RGD:7241557
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
G
ADRB2
adrenoceptor beta 2
susceptibility
IAGP ISO
DNA:polymorphisms: :p.G16R, p.Q27E, p.T164I mRNA:decreased expression:heart
RGD
PMID:15520258 PMID:12400771
RGD:1601126 , RGD:8548519
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO IAGP
mRNA:increased expression:left ventricle myocardium (rat) DNA:polymorphism:promoter:-429T>C (human)
RGD
PMID:19910580 PMID:16728681
RGD:2325647 , RGD:1625333
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGT
angiotensinogen
susceptibility
ISO EXP IEA IAGP
CTD Direct Evidence: marker/mechanism associated with Coronary Artery Disease;DNA:polymorphism: :p.M235T (human) associated with hypertension;DNA:polymorphism: :p.M235T
CTD RGD
PMID:1668233 PMID:16413583 PMID:21167013 PMID:15118671 PMID:11393670 PMID:17299437 More...
RGD:5129191 , RGD:1331525 , RGD:1566452 , RGD:1601132
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
susceptibility no_association
IAGP IEA ISO
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
RGD GAD
PMID:16061119 PMID:9857918 PMID:15118671 PMID:9652322
RGD:1601150 , RGD:1566499 , RGD:1331525 , RGD:10047101
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AHSG
alpha 2-HS glycoprotein
IEP
protein:increased expression:plasma
RGD
PMID:19029462
RGD:2313810
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
G
AIMP1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1
ISO
RGD
PMID:14732363
RGD:1580021
NCBI chr 4:106,315,544...106,349,456
Ensembl chr 4:106,315,544...106,349,456
G
AK1
adenylate kinase 1
treatment
ISO
RGD
PMID:22229508
RGD:11100025
NCBI chr 9:127,866,480...127,879,621
Ensembl chr 9:127,866,486...127,877,675
G
AKT1
AKT serine/threonine kinase 1
IEP ISO
protein:increased serine phosphorylation:platelet protein:decreased serine phosphorylation:heart
RGD
PMID:20467748 PMID:20352476
RGD:5509094 , RGD:10041035
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALDH2
aldehyde dehydrogenase 2 family member
IAGP
DNA:missense mutation: :p.E487K (human)
RGD
PMID:12452318
RGD:2311152
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
no_association
IAGP IEA
DNA:snps:multiple (human)
RGD GAD
PMID:14770184 PMID:15118671 PMID:19046748
RGD:1578317 , RGD:1331525 , RGD:2313891
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
ANG
angiogenin
IMP
RGD
PMID:18462761
RGD:2325719
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANGPT1
angiopoietin 1
ISO
mRNA, protein:decreased expression:myocardium
RGD
PMID:15364619
RGD:1626168
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
G
ANGPT2
angiopoietin 2
ISO
protein:increased expression:left ventricular wall, heart septum (rat)
RGD
PMID:16714360
RGD:1601493
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
G
ANXA5
annexin A5
susceptibility no_association
IAGP IEP ISO
DNA:polymorphism: :-1C>T (human) protein:increased expression:plasma protein:altered localization:cardiac muscle cell, sarcolemma
RGD
PMID:12200370 PMID:8814351 PMID:16025836 PMID:16501019
RGD:2317542 , RGD:2317543 , RGD:1578384 , RGD:2317541
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
susceptibility
IAGP
DNA:polymorphism:exon 5: G>A (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
G
APOA1
apolipoprotein A1
no_association
IDA IEA IAGP
DNA:polymorphisms
RGD GAD
PMID:20176799 PMID:15118671 PMID:10428310
RGD:2325759 , RGD:1331525 , RGD:1578442
NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622
G
APOA4
apolipoprotein A4
susceptibility no_association
IEA IAGP
associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.Q360H (human) DNA:mutation:intron:IVS2 (human)
GAD RGD
PMID:15118671 PMID:7958503 PMID:10428310
RGD:1331525 , RGD:5685678 , RGD:1578442
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOB
apolipoprotein B
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC3
apolipoprotein C3
no_association
IAGP IEA
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar RGD
PMID:10428310 PMID:15118671
RGD:1578442 , RGD:1331525
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOE
apolipoprotein E
susceptibility
IAGP EXP IEA
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations, haplotype:cds:p.C112R, p.C158R (human)
CTD RGD
PMID:10587578 PMID:17217375 PMID:10090925 PMID:15118671
RGD:1601229 , RGD:10449412 , RGD:1331525
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APOH
apolipoprotein H
IDA ISO
RGD
PMID:15322656 PMID:12826288
RGD:2313985 , RGD:10054111
NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
G
ATG7
autophagy related 7
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
G
ATM
ATM serine/threonine kinase
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24358288 PMID:24358288
RGD:10053570
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
G
ATP5F1D
ATP synthase F1 subunit delta
treatment
ISO
protein:decreased expression:myocardium (rat)
RGD
PMID:29300489 PMID:23809007
RGD:13792656 , RGD:13792681
NCBI chr19:1,241,751...1,244,825
Ensembl chr19:1,241,746...1,244,825
G
ATP5PO
ATP synthase peripheral stalk subunit OSCP
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
G
AVPR1A
arginine vasopressin receptor 1A
ISO
RGD
PMID:16423716
RGD:2300376
NCBI chr12:63,142,759...63,151,201
Ensembl chr12:63,142,759...63,151,201
G
BAK1
BCL2 antagonist/killer 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BAX
BCL2 associated X, apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20079142 PMID:25450231
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:17467744
RGD:1643494
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BDKRB1
bradykinin receptor B1
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
G
BDKRB2
bradykinin receptor B2
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BECN1
beclin 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:20079142
RGD:11561913
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BIRC5
baculoviral IAP repeat containing 5
ISO
RGD
PMID:15081314
RGD:2293137
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BNIP3
BCL2 interacting protein 3
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
BRAP
BRCA1 associated protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198608
NCBI chr12:111,642,146...111,685,956
Ensembl chr12:111,642,146...111,685,956
G
BRINP3
BMP/retinoic acid inducible neural specific 3
susceptibility
IAGP
DNA:SNPs:3' end:
RGD
PMID:18430236
RGD:14398488
NCBI chr 1:190,097,658...190,477,864
Ensembl chr 1:190,097,658...190,478,404
G
C3
complement C3
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16996480
RGD:1600605
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C7
complement C7
ISO
Protein:increased activity:serum, myocardium
RGD
PMID:15724448
RGD:1599522
NCBI chr 5:40,909,497...40,984,643
Ensembl chr 5:40,909,492...41,020,216
G
C8A
complement C8 alpha chain
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 1:56,854,797...56,918,223
Ensembl chr 1:56,854,768...56,918,223
G
C8B
complement C8 beta chain
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,207...56,974,383
G
CACYBP
calcyclin binding protein
ISO
mRNA:increased expression:heart
RGD
PMID:16440310
RGD:2326117
NCBI chr 1:174,999,435...175,012,027
Ensembl chr 1:174,999,163...175,012,027
G
CAMK2D
calcium/calmodulin dependent protein kinase II delta
treatment
ISO
mRNA, protein:splice variants, increased expression:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr 4:113,451,032...113,761,738
Ensembl chr 4:113,418,054...113,761,927
G
CASP1
caspase 1
severity ameliorates
ISO
RGD
PMID:17303764 PMID:33389498
RGD:2315913 , RGD:242905187
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CASP3
caspase 3
ameliorates treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25450231 PMID:28622474 PMID:27904666
RGD:329333030 , RGD:13782309
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASR
calcium sensing receptor
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:22527939
RGD:7205672
NCBI chr 3:122,183,668...122,291,629
Ensembl chr 3:122,183,668...122,291,629
G
CAT
catalase
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21600015 PMID:14575298
RGD:1581148
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV3
caveolin 3
ISO
Protein:increased expression:cytosol mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:12566108 PMID:29438664
RGD:1599542 , RGD:126925221
NCBI chr 3:8,733,802...8,746,758
Ensembl chr 3:8,733,802...8,841,808
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO IAGP
protein:increased expression:serum DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:18459941 PMID:18753699 PMID:16116069
RGD:2307033 , RGD:8549616 , RGD:1581161
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:18954648
RGD:4890013
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCN1
cellular communication network factor 1
ISO
mRNA,protein:increased expression:myocardium (mouse)
RGD
PMID:15117851
RGD:329845570
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCN2
cellular communication network factor 2
treatment
ISO
mRNA:increased expression:left ventricle (rat)
RGD
PMID:18167060 PMID:29849775
RGD:2314623 , RGD:35673318
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNA2
cyclin A2
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:23634243
RGD:10054471
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCR2
C-C motif chemokine receptor 2
IAGP
RGD
PMID:12719858 PMID:12853162
RGD:1581177 , RGD:1581174
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:18954648
RGD:4890013
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCT7
chaperonin containing TCP1 subunit 7
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
ClinVar
PMID:24213632
NCBI chr 2:73,234,308...73,253,005
Ensembl chr 2:73,233,420...73,253,021
G
CD14
CD14 molecule
no_association
IAGP
associated with Coronary Artery Disease;DNA:SNP:promoter
RGD
PMID:17436151 PMID:10195920 PMID:14587643
RGD:2314155 , RGD:1580252 , RGD:1580255
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD36
CD36 molecule (CD36 blood group)
severity
ISO
RGD
PMID:22128087
RGD:6893560
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD40LG
CD40 ligand
IEP
protein:increased expression:serum
RGD
PMID:17635572
RGD:2314209
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CD59
CD59 molecule (CD59 blood group)
ISO
protein:decreased expression:myocardium
RGD
PMID:7515561
RGD:1600501
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CDKN1B
cyclin dependent kinase inhibitor 1B
treatment
ISO
RGD
PMID:22492676 PMID:22492676
RGD:10045366 , RGD:10045366
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:24292258
RGD:11570534
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
CFTR
CF transmembrane conductance regulator
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:23221371
RGD:11566046
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CHI3L1
chitinase 3 like 1
IEP
protein:increased secretion:serum (human)
RGD
PMID:18480670
RGD:4892633
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
IAGP
DNA:polymorphism:promoter:-168A>G
RGD
PMID:15821736 PMID:17183695
RGD:1358146 , RGD:5491201
NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021
G
CKB
creatine kinase B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CKM
creatine kinase, M-type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722 PMID:12359538
NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875
G
CLU
clusterin
treatment
IDA
RGD
PMID:20854280
RGD:9068409
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL3A1
collagen type III alpha 1 chain
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
COL4A1
collagen type IV alpha 1 chain
susceptibility
IAGP
DNA:polymorphism: :p.Q1334H (human)
RGD
PMID:18077766
RGD:2311341
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202
G
COL6A3
collagen type VI alpha 3 chain
IAGP
DNA:SNP:CDS:E1386K (rs146092501) (human)
RGD
PMID:30226566
RGD:401851058
NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328
G
CREB1
cAMP responsive element binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREM
cAMP responsive element modulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CRP
C-reactive protein
ISO IEP
protein:increased expression:serum associated with Angina, Unstable;
RGD
PMID:21046814 PMID:9761079 PMID:22446866
RGD:5131456 , RGD:9491780 , RGD:6482304
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CS
citrate synthase
severity
ISO
protein:decreased expression:diaphragm, mitochondrion
RGD
PMID:1877670 PMID:34416105
RGD:243048469 , RGD:243048471
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
G
CSF2
colony stimulating factor 2
ISO
RGD
PMID:21326109
RGD:5131507
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSF3
colony stimulating factor 3
treatment
IDA
RGD
PMID:15639484
RGD:11039417
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CSNK2A1
casein kinase 2 alpha 1
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
G
CSNK2B
casein kinase 2 beta
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr 6:31,666,080...31,670,067
Ensembl chr 6:31,665,227...31,670,343
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
IAGP
DNA:SNP:CDS:49A>G (human)
RGD
PMID:17652883
RGD:2301976
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTSB
cathepsin B
ISO
protein:increased activity:serum, heart (rat)
RGD
PMID:19958779
RGD:2315501
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:19187644 PMID:11820456
RGD:2306567 , RGD:632503
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CYBA
cytochrome b-245 alpha chain
ISO
mRNA:increased expression:myocardium mRNA:increase expression:ventricle myocardium:
RGD
PMID:18762777 PMID:11243862
RGD:2317860 , RGD:1599690
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYBB
cytochrome b-245 beta chain
ISO
mRNA:increase expression:ventricle myocardium
RGD
PMID:11243862
RGD:1599690
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
CYP11B1
cytochrome P450 family 11 subfamily B member 1
ISO
RGD
PMID:18689429
RGD:2307303
NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,872,356...142,879,846
G
CYP11B2
cytochrome P450 family 11 subfamily B member 2
ISO
RGD
PMID:18689429
RGD:2307303
NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP2J2
cytochrome P450 family 2 subfamily J member 2
susceptibility
IAGP
DNA:polymorphism
RGD
PMID:17126841
RGD:1625380
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
IAGP
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
RGD
PMID:29804528
RGD:401901167
NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
G
DAB2
DAB adaptor protein 2
ISO
protein:increased expression:cardiomyocyte
RGD
PMID:20666606 PMID:21762377
RGD:7243156 RGD:7243158
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
G
DAB2IP
DAB2 interacting protein
onset
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:SNP:CDS:intron 1 (rs7025486) (human)
CTD RGD
PMID:20622881 PMID:20622881
RGD:401901599
NCBI chr 9:121,567,074...121,785,530
Ensembl chr 9:121,567,057...121,785,530
G
DAG1
dystroglycan 1
treatment
ISO
RGD
PMID:12034665
RGD:11541047
NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,713...49,535,618
G
DCN
decorin
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DDIT3
DNA damage inducible transcript 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DGKZ
diacylglycerol kinase zeta
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:17071729
NCBI chr11:46,332,926...46,380,554
Ensembl chr11:46,332,905...46,380,554
G
DVL1
dishevelled segment polarity protein 1
ISO
RGD
PMID:15256074
RGD:1580899
NCBI chr 1:1,335,278...1,349,418
Ensembl chr 1:1,335,276...1,349,418
G
DYRK1A
dual specificity tyrosine phosphorylation regulated kinase 1A
treatment
ISO
associated with heart failure; protein:increased expression, increased activity:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr21:37,365,573...37,526,358
Ensembl chr21:37,365,573...37,526,358
G
ECE1
endothelin converting enzyme 1
IEP
RGD
PMID:9607404
RGD:1580912
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
G
EDN1
endothelin 1
severity
IEP ISO
protein:increased secretion:plasma (human) mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:17893002 PMID:10573185
RGD:4144880 , RGD:1580921
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EDN2
endothelin 2
ISO
RGD
PMID:10573185
RGD:1580921
NCBI chr 1:41,478,775...41,484,683
Ensembl chr 1:41,478,775...41,484,683
G
EDNRA
endothelin receptor type A
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
EDNRB
endothelin receptor type B
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr13:77,895,487...77,975,527
Ensembl chr13:77,895,481...77,975,529
G
EGLN1
egl-9 family hypoxia inducible factor 1
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
G
EGLN3
egl-9 family hypoxia inducible factor 3
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
G
EPAS1
endothelial PAS domain protein 1
ISO
RGD
PMID:15247145 PMID:18484163
RGD:1580977 , RGD:5147886
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
G
EPHB1
EPH receptor B1
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr 3:134,795,260...135,260,467
Ensembl chr 3:134,795,260...135,260,467
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:19716829
RGD:5688358
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
EPO
erythropoietin
treatment
IDA EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19337937 PMID:21415704
RGD:10400907
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
EPOR
erythropoietin receptor
ISO
RGD
PMID:21415704
RGD:10400907
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
G
ERBB2
erb-b2 receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:26892146
RGD:11522702
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
G
ERBB4
erb-b2 receptor tyrosine kinase 4
treatment
ISO
RGD
PMID:26892146
RGD:11522702
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
G
ESR1
estrogen receptor 1
IEA IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:11894143 PMID:11919305 PMID:14600184 PMID:15133719 PMID:25741868 PMID:15118671 More...
RGD:1331525
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
F10
coagulation factor X
IAGP
ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to
ClinVar
PMID:10984565 PMID:12181036 PMID:25741868
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
G
F12
coagulation factor XII
susceptibility
IAGP
DNA:polymorphism:promoter:-46C>T(human)
RGD
PMID:16411408
RGD:11041803
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
G
F13A1
coagulation factor XIII A chain
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, protection against CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:8025280 PMID:9459313 PMID:9550516 PMID:10365735 PMID:10910914 PMID:12072871 PMID:12456499 PMID:17393027 PMID:25741868 PMID:12480694 More...
RGD:1581022
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
F2
coagulation factor II, thrombin
susceptibility
IAGP EXP
DNA:polymorphism::20210G>A(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9292507 PMID:9531249 PMID:10027711 PMID:12480694
RGD:1581022
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
F3
coagulation factor III, tissue factor
treatment
ISO
RGD
PMID:21229253
RGD:11062083
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
F5
coagulation factor V
susceptibility no_association
IAGP EXP
DNA:mutation:cds:1691G>A (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9531249 PMID:15131548 PMID:10590188
RGD:11564335 , RGD:11564337
NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588
G
F7
coagulation factor VII
susceptibility
IAGP EXP IEP
ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to ClinVar Annotator: match by term: Myocardial infarction, susceptibility to ClinVar Annotator: match by term: F7-related condition ClinVar Annotator: match by term: F7-related condition | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:missense mutation, repeat:cds, intron:p.R353Q, (human) protein:increased activity:plasma (human)
OMIM ClinVar CTD RGD
PMID:1634227 PMID:2070047 PMID:6812354 PMID:7919338 PMID:7981691 PMID:8242057 PMID:8844208 PMID:8883260 PMID:10554827 PMID:10862079 PMID:10984565 PMID:11129332 PMID:11931672 PMID:12181036 PMID:12903033 PMID:12935978 PMID:15142120 PMID:15456489 PMID:15735798 PMID:18282149 PMID:18669152 PMID:18976247 PMID:20040857 PMID:20735728 PMID:20958793 PMID:21902896 PMID:22180436 PMID:25582404 PMID:25741868 PMID:25828579 PMID:25952977 PMID:26105150 PMID:28492532 PMID:31064749 PMID:34355501 PMID:16116695 PMID:9420338 PMID:7495060 More...
RGD:1580374 , RGD:11049521 , RGD:2312409
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
FABP3
fatty acid binding protein 3
IEP
RGD
PMID:8326460
RGD:1582401
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
G
FGB
fibrinogen beta chain
IAGP IEA
RGD GAD
PMID:9437197 PMID:15118671
RGD:1580381 , RGD:1331525
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGF1
fibroblast growth factor 1
treatment
IDA
RGD
PMID:24200746
RGD:10449026
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:17439742
RGD:10402087
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
G
FGFR2
fibroblast growth factor receptor 2
ameliorates
ISO
RGD
PMID:19358330
RGD:155663664
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
FIS1
fission, mitochondrial 1
ISO
protein:increased expression:plantaris (rat)
RGD
PMID:24427319
RGD:11557988
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
G
FLT1
fms related receptor tyrosine kinase 1
ISO
RGD
PMID:16714360
RGD:1601493
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FLT3LG
fms related receptor tyrosine kinase 3 ligand
treatment
ISO
RGD
PMID:24184252
RGD:11049498
NCBI chr19:49,474,215...49,486,231
Ensembl chr19:49,474,207...49,486,231
G
FN1
fibronectin 1
ISO
protein:decreased expression:heart
RGD
PMID:19695229
RGD:2325720
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
protein:increased expression:paraventricular nucleus hypothalamus, paraventricular nucleus thalamus
RGD
PMID:27601012
RGD:405649741
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
treatment
ISO IAGP
mRNA, protein:decreased expression:heart DNA:SNP: :rs17817449 (human) associated with type 2 diabetes mellitus;DNA:SNP:intron:rs9939609 (human)
RGD
PMID:29997116 PMID:26772723 PMID:20031593 PMID:29997116
RGD:329812009 , RGD:11555187 , RGD:329901766 , RGD:329812009
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
FZD2
frizzled class receptor 2
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:9142123
RGD:4107058
NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:20462747
RGD:10449173
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GATA4
GATA binding protein 4
treatment
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:20200331 PMID:23948075
RGD:7327215
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
G
GATM
glycine amidinotransferase
ISO
RGD
PMID:31972362
RGD:329961305
NCBI chr15:45,361,124...45,402,227
Ensembl chr15:45,361,124...45,402,327
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:32782412 PMID:26192027
RGD:329961570 , RGD:329970290
NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,902,826
G
GCLC
glutamate-cysteine ligase catalytic subunit
susceptibility
IAGP EXP
DNA:snp:promoter:c.-129C>T (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:12598062 PMID:12598062
RGD:1302515
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12081989 PMID:12975258
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GGT1
gamma-glutamyltransferase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19419996
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GH1
growth hormone 1
treatment
IDA
RGD
PMID:12500159
RGD:11352745
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
G
GHRH
growth hormone releasing hormone
treatment
ISO
RGD
PMID:24373935
RGD:10401242
NCBI chr20:37,251,086...37,261,814
Ensembl chr20:37,251,086...37,261,819
G
GJA1
gap junction protein alpha 1
treatment
ISO
protein:decreased phosphorylation
RGD
PMID:22969867 PMID:29428663 PMID:22841862
RGD:7207261 , RGD:13592597 , RGD:7207262
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GJA4
gap junction protein alpha 4
IAGP
DNA:SNP:CDS:T allele of 1019C>T in Japanese men (p<0.001) associated with coronary artery disease; DNA:SNP:CDS:C allele of 1019C>T, amino acid P319S (p = 0.0026) in a Swiss population
RGD
PMID:12477941 PMID:15982495 PMID:16677656
RGD:1626626 , RGD:1580400 , RGD:1626615
NCBI chr 1:34,792,999...34,795,747
Ensembl chr 1:34,792,999...34,795,747
G
GJA5
gap junction protein alpha 5
treatment
ISO
RGD
PMID:29428663
RGD:13592597
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
G
GP1BA
glycoprotein Ib platelet subunit alpha
IAGP
RGD
PMID:15269835
RGD:1580432
NCBI chr17:4,932,277...4,935,023
Ensembl chr17:4,932,277...4,935,023
G
GP6
glycoprotein VI platelet
sexual_dimorphism treatment no_association susceptibility onset
IAGP IMP
DNA:missense mutation:CDS:c.13254T>C (p.S219P) (human) human protein in a mouse model DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) (human) DNA:missense mutation:exon 7:c.645213C>T (p.T249A) (human) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P) (human)
RGD
PMID:11571236 PMID:22814400 PMID:20723028 PMID:12417295 PMID:11571236 PMID:11571236 More...
RGD:401793749 , RGD:401824647 , RGD:401794407 , RGD:401793754 , RGD:401793749 , RGD:401793749
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:32026788
RGD:401793703
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
susceptibility
IEP
RGD
PMID:14573732
RGD:1600662
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16716347 PMID:16565311
RGD:10045368
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
ameliorates
IEP ISO
protein:decreased expression:blood serum (human)
RGD
PMID:9142022 PMID:28622474
RGD:329333022 , RGD:329333030
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:25119867
RGD:10401898
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
ClinVar
PMID:24213632
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr11:1,995,176...2,001,266
Ensembl chr11:1,995,166...2,004,552
G
HADH
hydroxyacyl-CoA dehydrogenase
ISO
RGD
PMID:11481570
RGD:2302229
NCBI chr 4:107,989,889...108,035,171
Ensembl chr 4:107,989,714...108,035,241
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
HFE
homeostatic iron regulator
susceptibility no_association
IAGP
RGD
PMID:10491370 PMID:12850485
RGD:1582697 , RGD:1582672
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
G
HGF
hepatocyte growth factor
treatment
IEP IDA
protein:increased expression:serum:
RGD
PMID:12419930 PMID:16570015
RGD:8548609 , RGD:8548632
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ameliorates treatment
ISO IMP
mRNA:increased expression:heart left ventricle human gene in a rat model
RGD
PMID:18484163 PMID:28622474 PMID:15247145 PMID:15999059
RGD:5147886 , RGD:329333030 , RGD:1580977 , RGD:9068466
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HMGB1
high mobility group box 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23188125
RGD:10402174
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:12392996 PMID:20925964
RGD:1598393 , RGD:4145134
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HP
haptoglobin
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:17068284 PMID:17207726 PMID:3990081 PMID:2613263
RGD:1626360 , RGD:1626354
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
ameliorates
ISO
RGD
PMID:28522730 PMID:26465199
RGD:329902054 , RGD:11087531
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO EXP
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17587755 PMID:17587755
RGD:2308939
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSPA5
heat shock protein family A (Hsp70) member 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:17202668
RGD:1624230
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10070497 PMID:23139358
RGD:8547733
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNA2
interferon alpha 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3597002
NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
G
IGF1
insulin like growth factor 1
severity
ISO IAGP
mRNA, protein:increased expression:myocardium
RGD
PMID:19295919 PMID:16635594
RGD:2306696 , RGD:1598421
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA,protein:increased expression:myocyte:
RGD
PMID:8682060
RGD:10046050
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IL10
interleukin 10
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:15466015
RGD:1598480
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL17A
interleukin 17A
ISO
mRNA, protein:increased expression:heart left ventricle (rat)
RGD
PMID:23096364
RGD:9095344
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL18BP
interleukin 18 binding protein
IDA
RGD
PMID:19805173
RGD:4889400
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
G
IL1B
interleukin 1 beta
ameliorates
ISO EXP
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:11743230 PMID:15883752 PMID:16310260 PMID:23143013 PMID:33389498 PMID:23237935 More...
RGD:7175553 , RGD:242905187 , RGD:7204425
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:18474815 PMID:19005744
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL4R
interleukin 4 receptor
ISO
mRNA:increased expression:heart
RGD
PMID:10807530
RGD:4889985
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15883752 PMID:16310260
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
ISO
RGD
PMID:12123772
RGD:1625444
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
INHBA
inhibin subunit beta A
ISO
mRNA:increased expression:heart (rat) mRNA:increased expression:myocardium (mouse)
RGD
PMID:14993131 PMID:32427381
RGD:1580888 , RGD:329849118
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
INHBB
inhibin subunit beta B
ISO
mRNA:increased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
G
ISL1
ISL LIM homeobox 1
ameliorates
IDA ISO
RGD
PMID:29482621 PMID:22727192
RGD:243048463 , RGD:243048464
NCBI chr 5:51,383,448...51,394,730
Ensembl chr 5:51,383,448...51,394,730
G
ITGA2
integrin subunit alpha 2
susceptibility no_association
IAGP
RGD
PMID:16697311 PMID:10194421 PMID:15227729
RGD:1582296 , RGD:1581029 , RGD:1582294
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA3
integrin subunit alpha 3
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:19041328
RGD:2325287
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
G
ITGAM
integrin subunit alpha M
treatment
ISO
RGD
PMID:29933226
RGD:329853753
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITGB1
integrin subunit beta 1
treatment
ISO
RGD
PMID:28367125
RGD:13602094
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
G
ITGB3
integrin subunit beta 3
no_association susceptibility
IAGP EXP
DNA:polymorphism:exon: ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with arteriosclerosis; DNA:polymorphism:exon
OMIM ClinVar CTD RGD
PMID:2014236 PMID:7570918 PMID:8598867 PMID:8667943 PMID:8838346 PMID:9700201 PMID:10583927 PMID:10727448 PMID:11723016 PMID:17264806 PMID:25728920 PMID:25741868 PMID:28492532 PMID:9716140 PMID:10531147 PMID:20846430 More...
RGD:5128498 , RGD:5128481 , RGD:5128476
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
IDA
RGD
PMID:10486281
RGD:1582334
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
G
JAK2
Janus kinase 2
susceptibility
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:22749532
RGD:10403083
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
treatment
ISO
RGD
PMID:23647964
RGD:7247426
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
G
KCNK2
potassium two pore domain channel subfamily K member 2
ISO
mRNA:decreased expression:heart left ventricle, epicardium, endocardium (rat)
RGD
PMID:21683547
RGD:9831182
NCBI chr 1:215,005,542...215,237,090
Ensembl chr 1:215,005,775...215,237,090
G
KCNN4
potassium calcium-activated channel subfamily N member 4
susceptibility
IAGP
DNA:SNPs,haplotypes:introns:multiple
RGD
PMID:19644414
RGD:329969896
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
G
KDM5B
lysine demethylase 5B
ameliorates
ISO
RGD
PMID:36481938
RGD:329901769
NCBI chr 1:202,724,495...202,808,421
Ensembl chr 1:202,724,495...202,808,487
G
KDM6A
lysine demethylase 6A
ISO
mRNA:increased expression:myocardium (rat)
RGD
PMID:30887465
RGD:151665136
NCBI chr X:44,873,188...45,112,779
Ensembl chr X:44,873,188...45,112,779
G
KDR
kinase insert domain receptor
treatment
IDA ISO
RGD
PMID:16698275 PMID:25936512
RGD:1581717 , RGD:126925214
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
KIF6
kinesin family member 6
no_association treatment
IAGP
DNA:SNP: :rs20455 (human) DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:18222354 PMID:20927332 PMID:26997531 PMID:19371834 PMID:20403483
RGD:243048446 , RGD:243048450 , RGD:243048449 , RGD:243048447 , RGD:11097528
NCBI chr 6:39,329,990...39,725,408
Ensembl chr 6:39,329,990...39,725,408
G
KLF13
KLF transcription factor 13
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr15:31,326,835...31,435,665
Ensembl chr15:31,326,835...31,435,665
G
KLK1
kallikrein 1
IAGP EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12411458 PMID:17022964
RGD:1641799
NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787
G
LAMP2
lysosomal associated membrane protein 2
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
G
LCAT
lecithin-cholesterol acyltransferase
ISO
RGD
PMID:16640830
RGD:1581773
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LCN2
lipocalin 2
ameliorates
ISO
RGD
PMID:27800610
RGD:126790572
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LDHA
lactate dehydrogenase A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LDLR
low density lipoprotein receptor
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LEFTY1
left-right determination factor 1
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr 1:225,886,282...225,889,146
Ensembl chr 1:225,886,282...225,911,382
G
LGALS2
galectin 2
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM CTD ClinVar RGD
PMID:15129282 PMID:15129282
RGD:1581852
NCBI chr22:37,570,248...37,580,087
Ensembl chr22:37,570,248...37,582,616
G
LGALS3
galectin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LINC01588
long intergenic non-protein coding RNA 1588
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:35258167
NCBI chr14:49,981,669...50,007,520
Ensembl chr14:49,927,571...50,105,102
G
LIPG
lipase G, endothelial type
susceptibility
IAGP
DNA:polymorphism: :584C>T (human)
RGD
PMID:17526978
RGD:1641818
NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185
G
LOC100287329
uncharacterized LOC100287329
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar
PMID:12426569 PMID:12746914 PMID:14681301
NCBI chr 6:31,559,571...31,572,703
G
LOC129930970
ATAC-STARR-seq lymphoblastoid silent region 1091
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar
PMID:12081989 PMID:12975258
NCBI chr 1:93,909,514...93,909,753
G
LOX
lysyl oxidase
ISO
RGD
PMID:14553832
RGD:1581883
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPA
lipoprotein(a)
IAGP
DNA:SNP:CDS:rs3798220, g.160961137T>C, p.Ile1891Met
RGD
PMID:18775538
RGD:5509091
NCBI chr 6:160,531,482...160,664,275
Ensembl chr 6:160,531,482...160,664,275
G
LPL
lipoprotein lipase
susceptibility
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :p.D9N (rs1801177) (human)
RGD
PMID:18823627
RGD:2313302
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRP1
LDL receptor related protein 1
susceptibility
IAGP
RGD
PMID:12402342
RGD:1581913
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LRP8
LDL receptor related protein 8
onset susceptibility no_association
IAGP EXP
DNA:missense mutation:cds:p.R952Q (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
CTD OMIM ClinVar RGD
PMID:17847002 PMID:17847002 PMID:18592168
RGD:2306124 , RGD:2306125
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
G
LRPAP1
LDL receptor related protein associated protein 1
susceptibility
IAGP
RGD
PMID:12394648
RGD:1581922
NCBI chr 4:3,503,612...3,532,422
Ensembl chr 4:3,503,612...3,532,446
G
LTA
lymphotoxin alpha
no_association susceptibility severity
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:SNP:exon:804C>A (p.T26N) (human)
ClinVar OMIM CTD RGD
PMID:12426569 PMID:12746914 PMID:14681301 PMID:15129282 PMID:15266304 PMID:25741868 PMID:15175864 PMID:23398946 PMID:12426569 More...
RGD:1581940 , RGD:8548841 , RGD:1580417
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:20079142
RGD:11561913
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:22635076
RGD:10412335
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:16183734 PMID:27121011
RGD:2298758 , RGD:11073666
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAPK1
mitogen-activated protein kinase 1
ISO
RGD
PMID:15653762
RGD:1582282
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK14
mitogen-activated protein kinase 14
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK8
mitogen-activated protein kinase 8
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MDH2
malate dehydrogenase 2
ISO
RGD
PMID:9753871
RGD:1582468
NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508
G
MDK
midkine
ISO
RGD
PMID:9568069
RGD:1582488
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MEF2A
myocyte enhancer factor 2A
TAS
RGD
PMID:15811259
RGD:1580548
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
MEF2C
myocyte enhancer factor 2C
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
G
MEOX2
mesenchyme homeobox 2
ISO
protein:decreased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 7:15,611,212...15,686,683
Ensembl chr 7:15,611,212...15,686,683
G
MESP1
mesoderm posterior bHLH transcription factor 1
treatment
IMP
human gene and cell line in a rat model
RGD
PMID:32550911
RGD:242905196
NCBI chr15:89,732,446...89,751,249
Ensembl chr15:89,749,875...89,751,249
G
MFF
mitochondrial fission factor
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23867156 PMID:23867156
RGD:12879458
NCBI chr 2:227,325,251...227,357,836
Ensembl chr 2:227,325,151...227,357,833
G
MFN2
mitofusin 2
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
G
MGP
matrix Gla protein
susceptibility
IAGP
RGD
PMID:11073842
RGD:1582503
NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857
G
MIA3
MIA SH3 domain ER export factor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609
NCBI chr 1:222,618,097...222,668,007
Ensembl chr 1:222,618,097...222,668,007
G
MIAT
myocardial infarction associated transcript
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism
CTD OMIM
PMID:17066261
NCBI chr22:26,646,429...26,676,478
Ensembl chr22:26,646,411...26,676,475
G
MIF
macrophage migration inhibitory factor
ISO IEP
mRNA, protein:increased expression:myocardium protein:increased expression:plasma
RGD
PMID:12704210 PMID:11589847
RGD:1642003 , RGD:1642008
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR125B2
microRNA 125b-2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29122578
NCBI chr21:16,590,237...16,590,325
Ensembl chr21:16,590,237...16,590,325
G
MIR143
microRNA 143
ISO
RNA:increased expression:myocardium: RNA:increased expression:plasma, left ventricle:
RGD
PMID:28887629 PMID:29728596
RGD:155882580 , RGD:155882581
NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
G
MIR145
microRNA 145
treatment ameliorates
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29956747 PMID:30146700 PMID:32890431
RGD:155260296 , RGD:155260294
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
G
MIR155
microRNA 155
treatment
ISO
RGD
PMID:31207208
RGD:21066347
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR208A
microRNA 208a
treatment
ISO
miRNA:increased expression:heart
RGD
PMID:26688617 PMID:26861724
RGD:11536862 , RGD:242905213
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
G
MIR223
microRNA 223
ISO
RNA:increased expression:heart
RGD
PMID:29608885
RGD:21408565
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR25
microRNA 25
ISO
RNA:increased expression:myocardium:
RGD
PMID:28887629
RGD:155882580
NCBI chr 7:100,093,560...100,093,643
Ensembl chr 7:100,093,560...100,093,643
G
MIR30A
microRNA 30a
treatment
ISO
RGD
PMID:29849775
RGD:35673318
NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
G
MIR30C1
microRNA 30c-1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr 1:40,757,284...40,757,372
Ensembl chr 1:40,757,284...40,757,372
G
MIR30E
microRNA 30e
ISO
miRNA:decreased expression:heart (rat)
RGD
PMID:25950484
RGD:11541106
NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446
G
MIR320A
microRNA 320a
treatment
ISO
RGD
PMID:19380620
RGD:155882541
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
MIR423
microRNA 423
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24253456
NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172
G
MIR761
microRNA 761
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23867156
NCBI chr 1:51,836,344...51,836,402
Ensembl chr 1:51,836,344...51,836,402
G
MLXIPL
MLX interacting protein like
susceptibility
IAGP
DNA:SNP:cd: C771G, p.Q241H (rs3812316) (human)
RGD
PMID:24448738
RGD:401799621
NCBI chr 7:73,593,202...73,647,907
Ensembl chr 7:73,593,194...73,624,543
G
MMP1
matrix metallopeptidase 1
susceptibility
IAGP ISO IMP IDA
associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human) protein:increased expression, increased activity:heart left ventricle (rat) human gene in rat model
RGD
PMID:16210545 PMID:8531210 PMID:11179039 PMID:19797822 PMID:15009768
RGD:1582520 , RGD:7207198 , RGD:7207136 , RGD:7207135 , RGD:1582535
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP13
matrix metallopeptidase 13
ISO
RGD
PMID:15782494
RGD:1582556
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
G
MMP14
matrix metallopeptidase 14
IDA
RGD
PMID:16461815
RGD:1582569
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
G
MMP2
matrix metallopeptidase 2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16310260 PMID:24358288 PMID:10773235 PMID:11179039
RGD:1582587 , RGD:7207136
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP3
matrix metallopeptidase 3
IAGP
RGD
PMID:15467919
RGD:1580551
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP7
matrix metallopeptidase 7
ISO
RGD
PMID:16769909
RGD:1582373
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
MMP9
matrix metallopeptidase 9
susceptibility
ISO EXP IAGP IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:heart left ventricle protein:increased expression, increased activity:heart left ventricle (rat) DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human) protein:increased expression:coronary artery, plasma (human)
CTD RGD
PMID:16310260 PMID:24358288 PMID:14729404 PMID:25520329 PMID:8531210 PMID:17893005 PMID:16845718 PMID:15118287 More...
RGD:1582639 , RGD:13204799 , RGD:7207198 , RGD:7207049 , RGD:1582653 , RGD:1582645
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MSTN
myostatin
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:190,055,700...190,062,729
Ensembl chr 2:190,055,700...190,062,729
G
MT-ND2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
IAGP
DNA:missense mutation: :m.5178C>A (p.L237M) (human)
RGD
PMID:15262184
RGD:1581054
NCBI chr MT:4,470...5,511
Ensembl chr MT:4,470...5,511
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
IAGP
associated with Kidney Failure, Chronic; DNA:transition:cds:g.677C>T rs1801133 (human) DNA:SNP: :677C>T (human)
RGD
PMID:19272686 PMID:10090925
RGD:6893548 , RGD:10449412
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MTOR
mechanistic target of rapamycin kinase
treatment
ISO
protein:decreased serine phosphorylation:heart associated with Diabetes Mellitus, Experimental
RGD
PMID:20352476 PMID:23773982
RGD:10041035 , RGD:10041040
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MYH6
myosin heavy chain 6
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
G
MYH7
myosin heavy chain 7
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11743230 PMID:15090263
RGD:11565830
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
G
NCAM1
neural cell adhesion molecule 1
ISO
mRNA, protein:increased expression:heart protein:alternative form, increased expression:myocardium
RGD
PMID:19853610 PMID:23462508
RGD:2325979 , RGD:40924663
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NDUFB5
NADH:ubiquinone oxidoreductase subunit B5
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:23290949 PMID:24915518
RGD:10412734 , RGD:10412738
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:19616538
RGD:10413879
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NGF
nerve growth factor
treatment
IEP IMP
protein:increased expression:myocardium
RGD
PMID:20360245 PMID:20360245
RGD:405100231 , RGD:405100231
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NLK
nemo like kinase
ISO
mRNA, protein:decreased expression:heart
RGD
PMID:26861724
RGD:242905213
NCBI chr17:28,042,677...28,206,074
Ensembl chr17:28,041,737...28,196,381
G
NLRP3
NLR family pyrin domain containing 3
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NONO
non-POU domain containing octamer binding
ameliorates
ISO
RGD
PMID:35247074
RGD:155882458
NCBI chr X:71,283,635...71,301,168
Ensembl chr X:71,254,814...71,301,522
G
NOS2
nitric oxide synthase 2
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10090345 PMID:11489778 PMID:26192027
RGD:329970290
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
susceptibility treatment
IAGP EXP ISO IMP
DNA:repeats:intron CTD Direct Evidence: marker/mechanism protein:decreased expression:aorta (rat) human gene in rat model DNA:duplication:intron:IVS4?-?+27 (human)
CTD RGD
PMID:10510054 PMID:16337503 PMID:10531147 PMID:29311930 PMID:28980197 PMID:22012955 PMID:17637430 PMID:12362496 PMID:11903359 More...
RGD:5128481 , RGD:13503346 , RGD:13450930 , RGD:7771563 , RGD:7771561 , RGD:1580283 , RGD:1580284
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPM1
nucleophosmin 1
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:21444791
RGD:11535018
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
G
NPPA
natriuretic peptide A
IAGP EXP ISO
DNA:snp:cds:c.2238T>C (human) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:9527094 PMID:11743230 PMID:12514664 PMID:16087130
RGD:1579982 , RGD:1580000
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NPPB
natriuretic peptide B
ISO IDA
RGD
PMID:19858735 PMID:17639095 PMID:17256064
RGD:2324680 , RGD:7247724 , RGD:1642266
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NPR1
natriuretic peptide receptor 1
susceptibility
IAGP
DNA:missense mutation:cds:p.M341I (human)
RGD
PMID:14646971
RGD:1580174
NCBI chr 1:153,678,688...153,693,992
Ensembl chr 1:153,678,688...153,693,992
G
NR1H3
nuclear receptor subfamily 1 group H member 3
susceptibility
IAGP
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR3C2
nuclear receptor subfamily 3 group C member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16413583 PMID:17587755
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
NRG1
neuregulin 1
treatment
IDA ISO
RGD
PMID:24200746 PMID:26892146 PMID:27993643
RGD:10449026 , RGD:11522702 , RGD:405145704
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
NRIP1
nuclear receptor interacting protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22503866
NCBI chr21:14,961,235...15,065,936
Ensembl chr21:14,961,235...15,065,936
G
OLR1
oxidized low density lipoprotein receptor 1
susceptibility
IAGP EXP
DNA:missense mutation:cds:p.K167N (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD RGD
PMID:12646194 PMID:12810610 PMID:14684693 PMID:25741868 PMID:12646194
RGD:1580996
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
G
OPA1
OPA1 mitochondrial dynamin like GTPase
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
G
OPRD1
opioid receptor delta 1
ISO
RGD
PMID:12798419 PMID:15076225
RGD:2316587 , RGD:9831425
NCBI chr 1:28,812,170...28,871,267
Ensembl chr 1:28,812,170...28,871,267
G
OPRK1
opioid receptor kappa 1
ISO
RGD
PMID:15076225
RGD:9831425
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
P2RY12
purinergic receptor P2Y12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19334620
NCBI chr 3:151,336,843...151,384,753
Ensembl chr 3:151,336,843...151,384,753
G
PAPPA
pappalysin 1
susceptibility
IAGP EXP
DNA:polymorphism:intron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11586954 PMID:17700210
RGD:1642324
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
protein:altered processing:left ventricle (mouse)
RGD
PMID:21282286
RGD:5684012
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PCSK2
proprotein convertase subtilisin/kexin type 2
IAGP
DNA:SNP:intron: (rs6080699) (human)
RGD
PMID:20036365
RGD:6483554
NCBI chr20:17,226,107...17,484,578
Ensembl chr20:17,226,107...17,484,578
G
PDE3A
phosphodiesterase 3A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr12:20,368,537...20,688,583
Ensembl chr12:20,368,537...20,688,583
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:17339532
RGD:2314468
NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804
G
PDGFD
platelet derived growth factor D
ISO
mRNA,protein:altered expression:myocardium:
RGD
PMID:21767547
RGD:9854703
NCBI chr11:103,907,189...104,164,147
Ensembl chr11:103,907,189...104,164,379
G
PEBP1
phosphatidylethanolamine binding protein 1
ISO
protein:decreased expression:right heart ventricle, ventricular septum
RGD
PMID:17089028
RGD:2302667
NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
G
PECAM1
platelet and endothelial cell adhesion molecule 1
onset no_association
IAGP
DNA:polymorphisms: :p.N563S, p.G670R (human) DNA:missense mutation:cds:p.R643G (human) DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:11795274 PMID:15488875 PMID:15265022
RGD:2311656 , RGD:6771224 , RGD:1581009
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PGF
placental growth factor
ISO IDA
RGD
PMID:20649603 PMID:21329947 PMID:22114497
RGD:6483584 , RGD:6483777 , RGD:6483773
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PHACTR1
phosphatase and actin regulator 1
susceptibility severity no_association
EXP IAGP IEP ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs9369640) (human) DNA:SNPs:multiple (human) DNA:SNP:intron:(rs12526453) (human) mRNA:increased expression:peripheral blood mononuclear cells (human) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300) (human) DNA:SNP:intron:g.13035530G>C (rs12526453) (human) mRNA, protein:decreased expression:heart left ventricle (rat)
CTD RGD
PMID:19198609 PMID:26098115 PMID:25738804 PMID:25838425 PMID:26086777 PMID:33460763 PMID:33460763 PMID:19198609 PMID:26098115 More...
RGD:11052994 , RGD:11052493 , RGD:11056926 , RGD:401900171 , RGD:401900171 , RGD:401851907 , RGD:11053274
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PHLDA3
pleckstrin homology like domain family A member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:20056919
RGD:6482688
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PLA2G7
phospholipase A2 group VII
IEP
protein:decreased expression:serum
RGD
PMID:19644070
RGD:6482786
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLAT
plasminogen activator, tissue type
treatment
IAGP EXP IDA
DNA:snp:enhancer:g.-7351C>T (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:1430592 PMID:1492007 PMID:1898952 PMID:1899364 PMID:1900011 PMID:2104561 PMID:2105625 PMID:2494454 PMID:2505604 PMID:2521976 PMID:3089627 PMID:3121335 PMID:7488445 PMID:7723950 PMID:7775709 PMID:7902905 PMID:8328192 PMID:8554022 PMID:8598594 PMID:9183334 PMID:10171637 PMID:10505926 PMID:10645301 PMID:10914357 PMID:11382373 PMID:11489769 PMID:12074692 PMID:12227717 PMID:12848087 PMID:15215796 PMID:15301905 PMID:18195371 PMID:19341228 PMID:20122609 PMID:11848437 PMID:7994806 More...
RGD:1580881 , RGD:11541077
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PLAU
plasminogen activator, urokinase
IAGP EXP IMP ISO
DNA:SNP:3' utr:c.*141C>T (rs4065) (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA, protein:increased expression:myocardium
CTD RGD
PMID:1908371 PMID:2174952 PMID:2382605 PMID:3068399 PMID:3984876 PMID:8416330 PMID:20518747 PMID:17653104 PMID:20952728 More...
RGD:6484126 , RGD:6484145 , RGD:6484133
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PLAUR
plasminogen activator, urokinase receptor
IEP ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:12393744 PMID:20952728
RGD:1580897 , RGD:6484133
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLCB1
phospholipase C beta 1
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360
G
PLCB3
phospholipase C beta 3
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr11:64,251,530...64,269,452
Ensembl chr11:64,251,530...64,269,150
G
PLN
phospholamban
treatment
ISO EXP
protein:decreased expression:heart left ventricle (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16026515 PMID:16162791 PMID:23781262 PMID:26067684
RGD:7327176 , RGD:11097969
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
PON1
paraoxonase 1
IAGP
RGD
PMID:10978258 PMID:10610741
RGD:1580202 , RGD:1580198
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
POSTN
periostin
ISO
protein:increased expression:heart:
RGD
PMID:24212842
RGD:10041024
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
PPARA
peroxisome proliferator activated receptor alpha
IAGP
DNA:SNP:intron:rs4253623, minor allele associated with increased risk
RGD
PMID:18549840
RGD:5562819
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARGC1A
PPARG coactivator 1 alpha
IEP EXP ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:heart
CTD RGD
PMID:22503866 PMID:22087236 PMID:22503866
RGD:6484266 , RGD:7242181
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PRKCE
protein kinase C epsilon
EXP ISO
CTD Direct Evidence: therapeutic RNA:decreased expression:myocardium:
CTD RGD
PMID:16782078 PMID:28887629
RGD:155882580
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRKD1
protein kinase D1
treatment
ISO
RGD
PMID:26064267
RGD:289474908
NCBI chr14:29,576,479...29,927,847
Ensembl chr14:29,576,479...30,191,898
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
IEP
RGD
PMID:10936861
RGD:11100014
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PRORP-PSMA6
PRORP-PSMA6 readthrough
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar
PMID:16845397 PMID:19282875 PMID:25741868
NCBI chr14:35,121,839...35,317,471
G
PSMA6
proteasome 20S subunit alpha 6
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:16845397 PMID:19282875 PMID:25741868
NCBI chr14:35,278,558...35,317,493
Ensembl chr14:35,278,633...35,317,493
G
PTGIS
prostaglandin I2 synthase
susceptibility
IAGP
DNA:SNP::1117C>A (human) DNA:silent mutation:exon 8:1117C>A (human) DNA:SNP:CDS: (rs5629) (human)
RGD
PMID:19040046 PMID:12040339 PMID:19327107 PMID:19046748
RGD:401901147 , RGD:401901268 , RGD:401901155 , RGD:2313891
NCBI chr20:49,503,874...49,568,137
Ensembl chr20:49,503,874...49,568,137
G
PTGS2
prostaglandin-endoperoxide synthase 2
IAGP
RGD
PMID:15138244
RGD:1581289
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTN
pleiotrophin
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:17925408
RGD:10044023
NCBI chr 7:137,227,341...137,343,733
Ensembl chr 7:137,227,341...137,343,774
G
RAD50
RAD50 double strand break repair protein
treatment
ISO
RGD
PMID:15623426
RGD:9831390
NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
G
RANBP1
RAN binding protein 1
ISO
protein:decreased expression:heart ventricle, cytoplasm (rat)
RGD
PMID:25341891
RGD:9835001
NCBI chr22:20,116,104...20,127,355
Ensembl chr22:20,115,938...20,127,355
G
RBP4
retinol binding protein 4
IEP
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
G
REG1A
regenerating family member 1 alpha
ISO
mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:15778284
RGD:9850130
NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409
G
REN
renin
susceptibility
IEP EXP
associated with Hypertension; protein:increased activity:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1668233 PMID:1759997
RGD:6892687
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
G
RETN
resistin
IEP
protein:increased expression:plasma
RGD
PMID:18997620
RGD:7207152
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
G
RPS6KB1
ribosomal protein S6 kinase B1
ISO
protein:increased threonine phosphorylation:heart left ventricle
RGD
PMID:16540832
RGD:1642998
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
RYR1
ryanodine receptor 1
ISO
protein:hyperphosphorylation:extensor digitorum longus:
RGD
PMID:12824280
RGD:329813076
NCBI chr19:38,433,691...38,587,564
Ensembl chr19:38,433,691...38,595,273
G
S100B
S100 calcium binding protein B
ISO EXP
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9788975 PMID:19910580
RGD:2325647
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
SDC1
syndecan 1
ISO
mRNA:increased expression:myocardium
RGD
PMID:9237025
RGD:2311712
NCBI chr 2:20,200,797...20,225,475
Ensembl chr 2:20,200,797...20,225,433
G
SDC4
syndecan 4
IEP
protein:increased expression:plasma
RGD
PMID:11372670
RGD:2312328
NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,424
G
SELL
selectin L
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:10070497
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
G
SELP
selectin P
susceptibility
IEP ISO IAGP
associated with Hypertension;protein:increased expression:plasma protein:increased expression:serum DNA:polymorphisms, haplotypes:cds:p.S290N, p.N562D, p.T715P (human)
RGD
PMID:17391113 PMID:21162967 PMID:21567088 PMID:12165563
RGD:2312304 , RGD:6219003 , RGD:6218991 , RGD:1580075
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINE1
serpin family E member 1
susceptibility
IAGP ISO
DNA:deletion:promoter:g.-676_-674delG (human)
RGD
PMID:12477941 PMID:16053971
RGD:1626626 , RGD:8547882
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFRP2
secreted frizzled related protein 2
ISO
RGD
PMID:19109969 PMID:19079247
RGD:4107088 , RGD:155883169
NCBI chr 4:153,780,591...153,789,083
Ensembl chr 4:153,780,591...153,789,083
G
SH2B3
SH2B adaptor protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr12:111,404,730...111,451,623
Ensembl chr12:111,405,923...111,451,623
G
SHH
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:20052412
RGD:12879408
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
SIRT1
sirtuin 1
ISO
protein:altered localization:nucleus
RGD
PMID:20089851
RGD:2316169
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SIRT3
sirtuin 3
treatment
ISO
RGD
PMID:24471974
RGD:9586050
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
G
SLC27A1
solute carrier family 27 member 1
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
G
SLC27A6
solute carrier family 27 member 6
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr 5:128,965,488...129,033,635
Ensembl chr 5:128,538,013...129,033,642
G
SLPI
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:23361363
RGD:9999400
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SMAD2
SMAD family member 2
treatment ameliorates
ISO
RGD
PMID:11087260 PMID:33409963
RGD:12903276 , RGD:401794430
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
G
SMAD3
SMAD family member 3
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SMAD4
SMAD family member 4
treatment
ISO
RGD
PMID:11087260
RGD:12903276
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
G
SOCS1
suppressor of cytokine signaling 1
ISO
protein:increased expression:heart
RGD
PMID:16377761
RGD:2298918
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
G
SOD1
superoxide dismutase 1
treatment
ISO EXP IMP
CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:21600015 PMID:11864929 PMID:22006090
RGD:1581222 , RGD:8655953
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
IEP EXP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12160945 PMID:2313102 PMID:9250167 PMID:14575298
RGD:1580840 , RGD:1580839 , RGD:1581148
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SOD3
superoxide dismutase 3
IDA IEP
RGD
PMID:14592844 PMID:14592844
RGD:1580841 , RGD:1580841
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:heart
RGD
PMID:12826287
RGD:2300056
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
G
SPP1
secreted phosphoprotein 1
IDA ISO
RGD
PMID:12939547 PMID:14500723
RGD:1581386 , RGD:1581325
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SRSF1
serine and arginine rich splicing factor 1
treatment
ISO
protein:increased phosphorylation:heart left ventricle(rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346
G
TBX3
T-box transcription factor 3
ISO
RGD
PMID:19341743
RGD:5132891
NCBI chr12:114,670,255...114,684,175
Ensembl chr12:114,670,255...114,684,175
G
TBX5
T-box transcription factor 5
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr12:114,353,911...114,408,442
Ensembl chr12:114,353,911...114,408,442
G
TEK
TEK receptor tyrosine kinase
ISO
protein:increased expression:ventricle myocardium
RGD
PMID:16714360
RGD:1601493
NCBI chr 9:27,109,225...27,230,174
Ensembl chr 9:27,109,141...27,230,174
G
TFPI
tissue factor pathway inhibitor
treatment
IDA ISO IEP
mRNA,protein:increased expression:heart:
RGD
PMID:15630488 PMID:21229253 PMID:14656922
RGD:11060131 , RGD:11062083 , RGD:11060139
NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
G
TGFB1
transforming growth factor beta 1
susceptibility
IAGP EXP ISO IEA
associated with Coronary Disease;DNA:polymorphism:promoter:-509C>T (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:heart:
CTD RGD
PMID:16310260 PMID:16543493 PMID:27121011 PMID:15118671
RGD:1601560 , RGD:11073666 , RGD:1331525
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB2
transforming growth factor beta 2
ISO
RGD
PMID:14575314
RGD:2302107
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TGFBR1
transforming growth factor beta receptor 1
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
TGFBR2
transforming growth factor beta receptor 2
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249
G
TH
tyrosine hydroxylase
no_association
IAGP
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
RGD
PMID:16139102
RGD:1580048
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
G
THBD
thrombomodulin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9843165 PMID:10627464
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
THBS1
thrombospondin 1
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16179730
RGD:2317960
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
TIMP2
TIMP metallopeptidase inhibitor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TLR4
toll like receptor 4
IAGP
DNA:SNP:intron:rs1927911, minor allele associated with decreased risk
RGD
PMID:15864121 PMID:18549840
RGD:1580734 , RGD:5562819
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TM6SF2
transmembrane 6 superfamily member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24633158
NCBI chr19:19,264,366...19,273,301
Ensembl chr19:19,264,364...19,273,391
G
TNC
tenascin C
ISO
protein:increased expression:heart, fibroblast
RGD
PMID:11454990
RGD:4889618
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
ISO EXP
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:21362018
RGD:5130892
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF11B
TNF receptor superfamily member 11b
IEP
RGD
PMID:15926884
RGD:1620893
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFRSF12A
TNF receptor superfamily member 12A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20082609
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF14
TNF receptor superfamily member 14
ISO
protein:increased expression:heart, cardiomyocyte, endothelial cell (rat)
RGD
PMID:18353719
RGD:2317281
NCBI chr 1:2,554,234...2,563,829
Ensembl chr 1:2,555,639...2,565,382
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
mRNA, protein:increased expression:left ventricle myocardium (rat)
RGD
PMID:15117889 PMID:20651834 PMID:21362018
RGD:1624194 , RGD:5130975 , RGD:5130892
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
mRNA, protein:decreased expression:left ventricle myocardium (rat)
RGD
PMID:21362018
RGD:5130892
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TNFSF11
TNF superfamily member 11
IEP
protein:increased expression:serum
RGD
PMID:18298349
RGD:2302363
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
G
TNFSF4
TNF superfamily member 4
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:15750594
RGD:1580396
NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,162,645...173,477,583
G
TNNI3
troponin I3, cardiac type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
G
TNNT2
troponin T2, cardiac type
IEP
RGD
PMID:15226628
RGD:1580441
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TREM1
triggering receptor expressed on myeloid cells 1
ameliorates disease_progression
ISO IEP
RGD
PMID:25840803 PMID:25840803 PMID:25840803
RGD:127284842 , RGD:127284842 , RGD:127284842
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
TRPV1
transient receptor potential cation channel subfamily V member 1
ISO
RGD
PMID:27671317
RGD:13792689
NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
G
TTN
titin
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
TXN
thioredoxin
IEP
RGD
PMID:14677813
RGD:1580785
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA:decreased expression:heart left ventricle (rat)
RGD
PMID:18515646
RGD:5134341
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UBD
ubiquitin D
ISO
mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:29438664
RGD:126925221
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
G
UTS2
urotensin 2
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr 1:7,847,612...7,913,249
Ensembl chr 1:7,843,083...7,853,512
G
UTS2R
urotensin 2 receptor
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr17:82,371,765...82,377,458
Ensembl chr17:82,371,765...82,377,458
G
VCAN
versican
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
G
VDAC1
voltage dependent anion channel 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
G
VDAC2
voltage dependent anion channel 2
treatment
ISO
RGD
PMID:20601275
RGD:10003049
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
G
VEGFA
vascular endothelial growth factor A
treatment
IEP ISO
protein:increased expression:serum,platelet:
RGD
PMID:10652191 PMID:25936512
RGD:7483604 , RGD:126925214
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFB
vascular endothelial growth factor B
IMP
RGD
PMID:17975666
RGD:2314324
NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264
G
VWF
von Willebrand factor
ISO
protein:increased expression:heart:
RGD
PMID:19435557
RGD:11080745
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
WDR12
WD repeat domain 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609 PMID:25915632
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WRN
WRN RecQ like helicase
IAGP
RGD
PMID:9021029
RGD:1580821
NCBI chr 8:31,033,810...31,176,138
Ensembl chr 8:31,033,788...31,176,138
G
XRCC3
X-ray repair cross complementing 3
susceptibility
IAGP
DNA:polymorphism:: (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
G
YBX1
Y-box binding protein 1
ISO
RGD
PMID:16002047
RGD:1580630
NCBI chr 1:42,682,418...42,703,805
Ensembl chr 1:42,682,418...42,703,805
G
ZEB2
zinc finger E-box binding homeobox 2
ISO
protein:increased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
G
ARHGAP17
Rho GTPase activating protein 17
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr16:24,919,389...25,015,369
Ensembl chr16:24,919,389...25,015,666
G
BAX
BCL2 associated X, apoptosis regulator
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
C3
complement C3
IEP
RGD
PMID:26476955
RGD:11552746
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CACNG4
calcium voltage-gated channel auxiliary subunit gamma 4
IEP
mRNA:decreased expression:blood:
RGD
PMID:27746059
RGD:13524557
NCBI chr17:66,964,707...67,033,398
Ensembl chr17:66,964,707...67,033,398
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CCN1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:30371213
RGD:329845516
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
DSC2
desmocollin 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
RGD
PMID:23054911
RGD:405650598
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
HEP
mRNA:increased expression:blood
RGD
PMID:35693610
RGD:329901852
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
GATA5
GATA binding protein 5
susceptibility
IAGP
DNA:SNPs:promoter:rs80197101, rs77067995 (human)
RGD
PMID:33684162
RGD:155260335
NCBI chr20:62,463,497...62,475,995
Ensembl chr20:62,463,497...62,475,995
G
GP6
glycoprotein VI platelet
ameliorates sexual_dimorphism
IAGP
DNA:missense mutation:CDS:p.S219P (rs1613662) (human) DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) (human)
RGD
PMID:20227257 PMID:20227257
RGD:401794138 , RGD:401794138
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
GPX3
glutathione peroxidase 3
IEP
protein:increased expression:plasma
RGD
PMID:28374671
RGD:401827832
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GSK3B
glycogen synthase kinase 3 beta
treatment ameliorates
ISO
RGD
PMID:26591365 PMID:32068187
RGD:13792778 , RGD:267358468
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:31755219
RGD:213230161
NCBI chr11:1,995,176...2,001,266
Ensembl chr11:1,995,166...2,004,552
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
IAGP
ClinVar Annotator: match by term: Acute myocardial infarction
ClinVar
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:25157968 PMID:26619011 More...
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
IFNG
interferon gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
G
IL10
interleukin 10
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL17A
interleukin 17A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1B
interleukin 1 beta
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL33
interleukin 33
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4
interleukin 4
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITGAM
integrin subunit alpha M
treatment
IEP
RGD
PMID:21238619
RGD:329901664
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
KIF6
kinesin family member 6
IAGP
DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:20044086
RGD:243048455
NCBI chr 6:39,329,990...39,725,408
Ensembl chr 6:39,329,990...39,725,408
G
MALAT1
metastasis associated lung adenocarcinoma transcript 1
ameliorates
ISO
RGD
PMID:29990866
RGD:155882565
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073
G
MIR126
microRNA 126
disease_progression
IEP
RGD
PMID:36523365 PMID:32595526
RGD:401851047 , RGD:401851053
NCBI chr 9:136,670,602...136,670,686
Ensembl chr 9:136,670,602...136,670,686
G
MIR146A
microRNA 146a
IEP
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MIR155
microRNA 155
IEP
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR17
microRNA 17
treatment
ISO
RGD
PMID:29536180
RGD:329403057
NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688
G
MIR21
microRNA 21
IEP
miRNA:increased expression:peripheral blood mononuclear cell, plasma RNA:decreased expression:serum
RGD
PMID:31866771 PMID:32595526
RGD:21081515 , RGD:401851053
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR223
microRNA 223
treatment
ISO
RGD
PMID:29689569
RGD:25823140
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR320A
microRNA 320a
ISO
RGD
PMID:29990866
RGD:155882565
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
G
NDUFB5
NADH:ubiquinone oxidoreductase subunit B5
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647
G
PF4
platelet factor 4
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
G
PLCG1
phospholipase C gamma 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
G
PPBP
pro-platelet basic protein
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
G
PTEN
phosphatase and tensin homolog
ameliorates
ISO IEP
mRNA:decreased expression:heart left ventricle (rat) RNA:increased expression:serum
RGD
PMID:26973267 PMID:29990866 PMID:32595526
RGD:11526378 , RGD:155882565 , RGD:401851053
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
RHOA
ras homolog family member A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
RIT2
Ras like without CAAX 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:42,743,227...43,115,685
Ensembl chr18:42,743,227...43,115,691
G
SDHB
succinate dehydrogenase complex iron sulfur subunit B
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,151
G
SERPING1
serpin family G member 1
IEP ISO
mRNA:increased expression:heart
RGD
PMID:26476955 PMID:26476955
RGD:11552746 , RGD:11552746
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
TBX1
T-box transcription factor 1
treatment
ISO
RGD
PMID:27422448
RGD:155882497
NCBI chr22:19,756,703...19,783,593
Ensembl chr22:19,756,703...19,783,593
G
TNF
tumor necrosis factor
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ZEB1
zinc finger E-box binding homeobox 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
G
EDN1
endothelin 1
IEP
protein:increased expression:aortic root, coronary sinus, plasma (human)
RGD
PMID:12581682
RGD:8661757
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:decreased expression, decreased activity:heart:
RGD
PMID:12615902 PMID:12615902
RGD:13208541 , RGD:13208541
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
EPO
erythropoietin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19337937
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
PLAT
plasminogen activator, tissue type
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21062213
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
MEF2A
myocyte enhancer factor 2A
IAGP EXP
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant, 1 CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery disease/myocardial infarction
ClinVar CTD OMIM
PMID:14645853 PMID:15496429 PMID:15841183 PMID:25741868
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
IAGP
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 2:27,217,369...27,243,943
Ensembl chr 2:27,217,369...27,243,943
G
LRP6
LDL receptor related protein 6
IAGP EXP
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:17332414 PMID:23703864 PMID:25741868 PMID:28492532
NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
G
NOS2
nitric oxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PLN
phospholamban
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
CDH5
cadherin 5
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
G
CTNNB1
catenin beta 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
JUP
junction plakoglobin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,754,604...41,786,931
G
ABCB1
ATP binding cassette subfamily B member 1
treatment
IAGP
DNA:SNPs: :rs1045642,rs7779562(human)
RGD
PMID:25217066
RGD:14700903
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ATP5MC2
ATP synthase membrane subunit c locus 2
severity
IEP
RGD
PMID:27441480
RGD:14696800
NCBI chr12:53,665,170...53,681,423
Ensembl chr12:53,632,726...53,677,408
G
CCN1
cellular communication network factor 1
sexual_dimorphism
IEP
protein:increased expression:blood serum (human)
RGD
PMID:34597881
RGD:329845519
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
LGALS3
galectin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
MIR208A
microRNA 208a
severity
ISO
miRNA:increased expression:blood
RGD
PMID:32458401
RGD:213230165
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all